These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34367244)

  • 1. RESIC: A Tool for Comprehensive Adenosine to Inosine RNA Editing Site Identification and Classification.
    Light D; Haas R; Yazbak M; Elfand T; Blau T; Lamm AT
    Front Genet; 2021; 12():686851. PubMed ID: 34367244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Bona Fide RNA Editing Sites: History, Challenges, and Opportunities.
    Tan MH
    Acc Chem Res; 2023 Nov; 56(21):3033-3044. PubMed ID: 37827987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance.
    Porath HT; Knisbacher BA; Eisenberg E; Levanon EY
    Genome Biol; 2017 Oct; 18(1):185. PubMed ID: 28969707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-selective versus promiscuous A-to-I editing.
    Wahlstedt H; Ohman M
    Wiley Interdiscip Rev RNA; 2011; 2(6):761-71. PubMed ID: 21976281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of A-to-I Hyper-edited RNA Sequences.
    Cohen-Fultheim R; Levanon EY
    Methods Mol Biol; 2021; 2181():213-227. PubMed ID: 32729083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational approaches for detection and quantification of A-to-I RNA-editing.
    Pinto Y; Levanon EY
    Methods; 2019 Mar; 156():25-31. PubMed ID: 30465820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
    Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
    Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
    Schaffer AA; Levanon EY
    Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-to-I RNA Editing Affects lncRNAs Expression after Heat Shock.
    Haas R; Ganem NS; Keshet A; Orlov A; Fishman A; Lamm AT
    Genes (Basel); 2018 Dec; 9(12):. PubMed ID: 30551666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome-wide identification of adenosine-to-inosine editing using the ICE-seq method.
    Suzuki T; Ueda H; Okada S; Sakurai M
    Nat Protoc; 2015 May; 10(5):715-32. PubMed ID: 25855956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey on cellular RNA editing activity in response to Candida albicans infections.
    Huang Y; Cao Y; Li J; Liu Y; Zhong W; Li X; Chen C; Hao P
    BMC Genomics; 2018 Jan; 19(Suppl 1):43. PubMed ID: 29363428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.